Safety and Efficacy of Mexidol® for ADHD in Children Aged 6-12

PHASE3CompletedINTERVENTIONAL
Enrollment

333

Participants

Timeline

Start Date

July 13, 2019

Primary Completion Date

July 13, 2020

Study Completion Date

July 13, 2020

Conditions
Attention Deficit Hyperactivity Disorder (ADHD)Anxiety Disorders and Symptoms
Interventions
DRUG

Mexidol

125 mg tablets

DRUG

Placebo

Placebo tablets

DRUG

Mexidol + Placebo

Combination of Mexidol and Placebo

Trial Locations (14)

117997

"Federal State Autonomous Educational Institution of Higher Education Russian National Research Medical University named after N.I. Pirogov Ministry of Health of the Russian Federation", Moscow

129344

"State Budgetary Healthcare Institution of the City of Moscow Scientific and Practical Center for Child Psychoneurology of the Moscow Department of Healthcare", Moscow

170100

"Federal State Budgetary Educational Institution of Higher Education Tver State Medical University Ministry of Health of the Russian Federation", Tver'

192148

"Limited Liability Company Medical Technologies", Saint Petersburg

350007

"State Budgetary Healthcare Institution Specialized Clinical Psychiatric Hospital №1 of the Ministry of Health of the Krasnodar Territory", Krasnodar

350051

"Limited Liability Company Center for Professional Therapy", Krasnodar

410005

"Limited Liability Company DNA Research Center", Saratov

420012

"Federal State Budgetary Educational Institution of Higher Education Kazan State Medical University Ministry of Health of the Russian Federation", Kazan'

432026

"State Healthcare Institution Central Clinical Medical-Sanitary Unit named after Honored Doctor of Russia V.A. Egorov", Ulyanovsk

460015

"State Budgetary Healthcare Institution Orenburg Regional Clinical Psychiatric Hospital №1", Orenburg

603006

"Limited Liability Company NizhMedClinic", Nizhny Novgorod

620075

"State Autonomous Healthcare Institution of the Sverdlovsk Region Multispecialty Clinical Medical Center 'Bonum'", Yekaterinburg

620144

"Limited Liability Company European Medical Center 'UGMK-Health'", Yekaterinburg

625000

"Federal State Budgetary Educational Institution of Higher Education Tyumen State Medical University Ministry of Health of the Russian Federation", Tyumen

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pharmasoft

INDUSTRY